Sort
25,944 grants matching “neurodegeneration”
Mayo Alzheimer's Disease Research Center
$1,899,952Ronald C Petersen · Mayo Clinic Rochester · P50 · FY2012 · AG
Novel Therapeutics for Prion Diseases
$1,899,821Stanley B Prusiner · University Of California, San Francisco · P01 · FY2011 · AG
Boston University Alzheimer's Disease Center
$1,898,738Neil W. Kowall · Boston University Medical Campus · P30 · FY2020 · AG
Boston University Alzheimer's Disease Center
$1,898,738Neil W. Kowall · Boston University Medical Campus · P30 · FY2019 · AG
Multisensory, Motor, and Biomarker Changes in Aging and Preclinical Alzheimer's Disease
$1,898,437Natascha Merten · University Of Wisconsin-Madison · RF1 · FY2020 · AG
Degenerative and Dementing Diseases of Aging
$1,898,028Stanley B Prusiner · University Of California, San Francisco · P01 · FY2011 · AG
Parkinson's Disease and Dementia
$1,897,510John Q. Trojanowski · University Of Pennsylvania · P50 · FY2009 · NS
Two-photon Imaging of Oxygen and Blood Flow in Retinal and Cerebral Vasculature
$1,897,240Sava Sakadzic · Massachusetts General Hospital · RF1 · FY2021 · NS
Functional Imaging of The Brain
$1,897,172Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Roles Of Brain Neuroimmune System In Neurodegeneration
$1,896,480Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Genetic Architecture of Alzheimerâs disease Proteinopathies
$1,895,864M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Novel Therapeutics for Prion Diseases
$1,895,717Stanley B Prusiner · University Of California, San Francisco · P01 · FY2009 · AG
Differential impact of Alzheimer disease on neuronal subpopulations in dorsal hippocampal CA1
$1,895,046Arjun Vijay Masurkar · New York University School Of Medicine · RF1 · FY2021 · AG
Modulating microglial function to restore A-beta proteostasis in Alzheimer's Disease
$1,894,783Warren G Tourtellotte · Cedars-Sinai Medical Center · RF1 · FY2021 · AG
Novel Therapeutics for Prion Diseases
$1,893,873Stanley B Prusiner · University Of California, San Francisco · P01 · FY2012 · AG
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
$1,892,819Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2021 · NS
Parkinson's Disease and Dementia
$1,891,590John Q. Trojanowski · University Of Pennsylvania · P50 · FY2008 · NS
In vivo monitoring of oxidative protein folding through time-resolved quantitative mass spectrometry
$1,890,000Arun P. Wiita · University Of California, San Francisco · DP2 · FY2016 · GM
Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimerâs disease
$1,887,634Xianlin Han · University Of Texas Hlth Science Center · RF1 · FY2021 · AG
Behavior and Neural Plasticity in the Aged
$1,887,352Carl W Cotman · University Of California-Irvine · P01 · FY2011 · AG
Leveraging the 24-hour movement paradigm to preserve cognitive function and prevent Alzheimer's disease: The Multi-Ethnic Study of Atherosclerosis (MESA) 24H-ACT Study
$1,886,663Keith M Diaz · Columbia University Health Sciences · R01 · FY2023 · AG
Innate and Adaptive Immunity in Parkinson Disease
$1,885,412David G Standaert · University Of Alabama At Birmingham · P50 · FY2021 · NS
ApoE Receptor Biology and Neurodegeneration
$1,885,220Mary Jo Ladu · University Of Illinois At Chicago · P01 · FY2012 · AG
Mechanisms of Autophagy
$1,882,599Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
ApoE Receptor Biology and Neurodegeneration
$1,878,193Mary Jo Ladu · University Of Illinois At Chicago · P01 · FY2011 · AG